Studies of vascular tolerance to nitroglycerin: Effects of N- acetylcysteine, N(G)-monomethyl L-arginine, and endothelin-1

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 3, 1996, Pages 418-424

  Lawson, D L ^a   Haught, W H ^a   Mehta, P ^a   Mehta, J L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Cyclic GMP; Endothelium derived relaxing factor; Nitroglycerin; Tolerance

Indexed keywords

ACETYLCHOLINE; ACETYLCYSTEINE; CYCLIC GMP; ENDOTHELIN 1; ENDOTHELIUM DERIVED RELAXING FACTOR; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; N(G) METHYLARGININE; NORADRENALIN; THIOL DERIVATIVE;

ANIMAL TISSUE; AORTA MEDIA; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CONTROLLED STUDY; CROSS TOLERANCE; DOSE RESPONSE; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCYSTEINE; ANIMALS; AORTA; CYCLIC GMP; DRUG TOLERANCE; ENDOTHELIN-1; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITROGLYCERIN; OMEGA-N-METHYLARGININE; RATS; VASODILATOR AGENTS;

EID: 0029796598     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199609000-00011     Document Type: Article

References (32)

1. Brien JF, McLaughlin BE, Breedon TH, Bennett BM, Nakatsu K, Marks GS. Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta. J Pharmacol Exp Ther 1986;237:608-14.
2. Axelsson KL, Ahlner J. Nitrate tolerance from a biochemical point of view. Drugs 1987;33:63-8.
3. Waldman SA, Rapoport RM, Ginsburg R, Murad F. Desensitization to nitroglycerin in vascular smooth muscle from rat and human. Biochem Pharmacol 1986;35:3525-31.
4. Romanin CH, Kumovetz WR. Tolerance to nitroglycerin is caused by reduced guanylate cyclase activation. J Mol Cell Cardiol 1989;21:41-8.
5. Needleman P, Johnson EM. Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther 1973;184: 709-15.
6. Ignarro LJ, Kadowitz PJ. The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Pharmacol Toxicol 1985;25:171-91.
7. Ignarro LJ, Lippton H, Edwards JC. et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 1981;218:739-49.
8. Mülsch A, Busse R, Bassenge E, Desensitization of guanylate cyclase in nitrate tolerance does not impair endothelium-dependent responses. Eur J Pharmacol 1988;158:191-8.
9. Berkenboom G, Fontaine J, Degre S. Persistence of the response to SIN1 on isolated coronary arteries rendered tolerant to nitroglycerin in vitro or in vivo. J Cardiovasc Pharmacol 1988;12:345-9.
10. Molina CR, Andersen JW, Rapoport RM, Waldman S, Murad F. Effect of in vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta. J Cardiovasc Pharmacol 1987;10:371-8.
11. Ljusegren ME, Ahlner J, Axelsson KL. Studies on vascular smooth muscle tolerance to different cGMP-mediated vasodilators and cross-tolerance to glyceryl trinitrate. Pharmacol Toxicol 1988;62:302-7.
12. Henry PJ, Drummer OH, Horowitz. J. 5-Nitrothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators. Br J Pharmacol 1989;98:757-66.
13. Mehta JL, Lawson DL, Yang BC, Mehta P, Nichols WW. Modulation of vascular tone by endothelin-1: role of preload, endothelial integrity and concentration of endothelin-1. Br J Pharmacol 1992;106:127-32.
14. Katsuki S, Arnold WP, Mittal CK, Jurad F. Effects of sodium nitroprusside, nitroglycerin, and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues. J Cyclic Nucleotide Protein Phosphor Res 1977;3: 239-47.
15. Kukovetz WR, Holzmann S. Mechanisms of nitrate-induced vasodilatation and tolerance. Eur J Clin Pharmacol 1990;38: S9-14.
16. Horowitz JD, Antman EM, Lorell BH, Barry WN, Smith TW. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine. Circulation 1983;68:1247-53.
17. Torresi J, Horowitz JD, Dusting GJ. Prevention and reversal of tolerance to nitroglycerin with N-acetylcysteine. J Cardiovasc Pharmacol 1985;7:777-83.
18. Winniford MD, Kennedy PL, Wells PJ, Hillis LD. Potentiation of nitroglycerin-induced coronary dilation by N-acetylcysteine. Circulation 1986;73:138-42.
19. Lawson DL, Nichols WW, Mehta P, Mehta JL. Captopril-induced reversal of nitroglycerin tolerance: role of sulfhydryl group vs. ACE inhibitory activity. J Cardiovasc Pharmacol 1991;17:411-8.
20. Parker JO, Farrell B, Laney KA, Rose BF. Nitrate tolerance: the lack of effect of N-acetylcysteine. Circulation 1987;76:572-6.
21. Nader D, Makhoul N, Flugelman MY. Failure of angiotensin converting enzyme inhibition to prevent nitrate tolerance in heart failure. Am J Cardiol 1990;66:609-13.
22. Mehta JL, Lawson DL, Nichols WW. Recovery of vascular smooth muscle relaxation from nitroglycerin-induced tolerance following a drug-free interval: a time-course in vitro study. Biochem Pharmacol 1991:41:743-7.
23. Kowaluk E, Hough K, Fung HL. Effect of intermittent exposure and drug-free intervals on the in vitro vascular tolerance to nitroglycerin. Life Sci 1989;44:1157-63.
24. Boesgaard S, Aldershvile J, Poulsen HE, Loft S, Andersson ME, Meister A. Nitrate tolerance in vivo is not associated with depletion of arterial or venous thiol levels. Circ Res 1994;74:115-20.
25. Rapoport RM, Waldman SA, Ginsbury R, Molina CR, Murad F. Effects of glyceryl trinitrate on endothelium-dependent and independent relaxation and cyclic GMP levels in rat aorta and human coronary artery. J Cardiovasc Pharmacol 1987;10:82-90.
26. Dinerman JL, Lawson DL, Mehta JL. Interaction between nitroglycerin and endothelium in vascular smooth muscle relaxation. Am J Physiol 1991;260:H968-71.
27. Moncada S, Rees DD, Schulz R, Palmer RMJ. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA 1991;88:2166-70.
28. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989;86:3375-8.
29. Boulanger C, Lüscher TF. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest 1990;85:587-90.
30. Lüscher TF, Yang Z, Tschudi M, et al. Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ Res 1990;66:1088-94.
31. Oshii K, Warner TD, Sheng H, Murad F. Endothelin-1 stimulates cyclic GMP formation in porcine kidney epithelial cells via activation of the L-arginine-dependent soluble guanylate cyclase pathway. J Cardiovasc Pharmacol 1991;15 (suppl):S246-50.
32. Lamontagne D, Pohl U, Busse R. Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. Circ Res 1992;70:123-30.